People living with mental health conditions deserve the highest standards of safe, effective, life-saving treatment. We are a Public Benefit Corporation accelerating technology and research to ensure access to care for patients of all backgrounds.
Mental health disorders are one of the leading causes of death and disability worldwide, impacting more than 1 in 4 people each year.
Clinicians are in need of more “evidence-based pharmacotherapy” for powerful treatments such as ketamine, which have shown significant outcomes such as rapid reduction of suicidal ideation
American Journal of Psychiatry
Real-world evidence can ”accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them.”
To empower clinicians and researchers to bring innovative mental health treatments to patients who need it most.
We are scientists, technologists, psychiatrists, and other mission-driven professionals passionate about generating new evidence-based medicine to improve the lives of people with moderate to severe mental health conditions. As a Public Benefit Corporation, Osmind is committed to supporting the development of new, effective treatments for moderate to severe mental health conditions, and to ensure access to care for patients of all backgrounds. We achieve this through rigorous research, advocacy, and modern technology that will most effectively help the medical community advance breakthrough therapies.
Lucia Huang, MBA
Co-founder and CEO
Jimmy Qian, MS
Co-founder and COO
Former CEO & Chairman, Allergan
Justin Kao, JD, MBA, MS
Partner, DFJ Growth
Maurizio Fava, MD
Psychiatrist-in-Chief, Massachusetts General Hospital
Robin Carhart-Harris, PhD
Ralph Metzner Distinguished Professor of Neurology and Psychiatry, UCSF
Charles DeBattista, MD
Professor of Psychiatry, Director of the Depression Research Clinic, Stanford
Boris Heifets, MD, PhD
Assistant Professor of Anesthesiology, and by courtesy Psychiatry, Stanford
Carolyn Rodriguez, MD, PhD
Associate Professor of Psychiatry and Behavioral Science, Stanford
Co-founder and past President & CEO of Verana Health; Operating Partner at Linden Capital Partners
CFO at Sophia Genetics; previously COO and CFO at Click Therapeutics, Senior Managing Director & Partner, Equity Research at Evercore
Founder of Syapse
Join our team supporting clinicians and researchers advancing life-saving treatments for people living with mental health conditions.